Do-1

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameDo-1
Drug Alias NameJNJ-38877618OMO-1Do-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitors
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsLung NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesDeuterOncology NVShanghai Allist Pharmaceutical Technology Co Ltd
Inactive CompaniesOctimet Oncology NvJanssen Cilag N.V./S.A.
Active IndicationsLung Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A